CTNNB1 and hepatocellular carcinoma: reported that HCC exhibiting β-catenin CTNNB1 mutations displays iso-high intensity in the hepatobiliary phase (HBP) of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-MRI) (78, 79), and HCC patients with CTNNB1 mutations have a better prognosis compared with patients with other types of HCC (80, 81).